European Resuscitation Council Guidelines for Resuscitation: 2018 Update – Antiarrhythmic drugs for cardiac arrest

Jasmeet Soar; Gavin D. Perkins; Ian Maconochie; Bernd W. Böttiger; Charles D. Deakin; Claudio Sandroni; Theresa M. Olasveengen; Jonathan Wyllie; Robert Greif; Andrew Lockey; Federico Semeraro; Patrick Van de Voorde; Carsten Lott; Leo Bossaert; Koenraad G. Monsieurs; Jerry P. Nolan

doi:10.1016/j.resuscitation.2018.11.018

European Resuscitation Council Guidelines for Resuscitation: 2018 Update – Antiarrhythmic drugs for cardiac arrest

Jasmeet Soar^*
, Gavin D. Perkins
, Ian Maconochie
, Bernd W. Böttiger
, Charles D. Deakin
, Claudio Sandroni
, Theresa M. Olasveengen
, Jonathan Wyllie
, Robert Greif
, Andrew Lockey
, Federico Semeraro
, Patrick Van de Voorde
, Carsten Lott
, Leo Bossaert
, Koenraad G. Monsieurs
, Jerry P. Nolan

^*Corresponding author for this work

Bristol Medical School (THS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

57 Citations (Scopus)

Abstract

This European Resuscitation Council (ERC) Guidelines for Resuscitation 2018 update is focused on the role of antiarrhythmic drugs during advanced life support for cardiac arrest with shock refractory ventricular fibrillation/pulseless ventricular tachycardia in adults, children and infants. This update follows the publication of the International Liaison Committee on Resuscitation (ILCOR) 2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations (CoSTR). The ILCOR CoSTR suggests that any beneficial effects of amiodarone or lidocaine are similar. This ERC update does not make any major changes to the recommendations for the use of antiarrhythmic drugs during advanced life support for shock refractory cardiac arrest.

Original language	English
Pages (from-to)	99-103
Number of pages	5
Journal	Resuscitation
Volume	134
DOIs	https://doi.org/10.1016/j.resuscitation.2018.11.018
Publication status	Published - Jan 2019

Bibliographical note

Publisher Copyright:
© 2018 Elsevier B.V.

Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.

Keywords

Advanced life support
Amiodarone
Antiarrhythmic drugs
Cardiopulmonary resuscitation
Guidelines
Heart arrest
Lidocaine
Neonatal life support
Paediatric life support
Pulseless ventricular tachycardia
Ventricular fibrillation

Access to Document

10.1016/j.resuscitation.2018.11.018

Handle.net

Persistent link

Cite this

Soar, J., Perkins, G. D., Maconochie, I., Böttiger, B. W., Deakin, C. D., Sandroni, C., Olasveengen, T. M., Wyllie, J., Greif, R., Lockey, A., Semeraro, F., Van de Voorde, P., Lott, C., Bossaert, L., Monsieurs, K. G., & Nolan, J. P. (2019). European Resuscitation Council Guidelines for Resuscitation: 2018 Update – Antiarrhythmic drugs for cardiac arrest. Resuscitation, 134, 99-103. https://doi.org/10.1016/j.resuscitation.2018.11.018

@article{be2625fc05d04e05b9413e22ef72078a,

title = "European Resuscitation Council Guidelines for Resuscitation: 2018 Update – Antiarrhythmic drugs for cardiac arrest",

abstract = "This European Resuscitation Council (ERC) Guidelines for Resuscitation 2018 update is focused on the role of antiarrhythmic drugs during advanced life support for cardiac arrest with shock refractory ventricular fibrillation/pulseless ventricular tachycardia in adults, children and infants. This update follows the publication of the International Liaison Committee on Resuscitation (ILCOR) 2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations (CoSTR). The ILCOR CoSTR suggests that any beneficial effects of amiodarone or lidocaine are similar. This ERC update does not make any major changes to the recommendations for the use of antiarrhythmic drugs during advanced life support for shock refractory cardiac arrest.",

keywords = "Advanced life support, Amiodarone, Antiarrhythmic drugs, Cardiopulmonary resuscitation, Guidelines, Heart arrest, Lidocaine, Neonatal life support, Paediatric life support, Pulseless ventricular tachycardia, Ventricular fibrillation",

author = "Jasmeet Soar and Perkins, \{Gavin D.\} and Ian Maconochie and B{\"o}ttiger, \{Bernd W.\} and Deakin, \{Charles D.\} and Claudio Sandroni and Olasveengen, \{Theresa M.\} and Jonathan Wyllie and Robert Greif and Andrew Lockey and Federico Semeraro and \{Van de Voorde\}, Patrick and Carsten Lott and Leo Bossaert and Monsieurs, \{Koenraad G.\} and Nolan, \{Jerry P.\}",

year = "2019",

month = jan,

doi = "10.1016/j.resuscitation.2018.11.018",

language = "English",

volume = "134",

pages = "99--103",

journal = "Resuscitation",

issn = "0300-9572",

publisher = "Elsevier Science Ireland",

}

Soar, J, Perkins, GD, Maconochie, I, Böttiger, BW, Deakin, CD, Sandroni, C, Olasveengen, TM, Wyllie, J, Greif, R, Lockey, A, Semeraro, F, Van de Voorde, P, Lott, C, Bossaert, L, Monsieurs, KG & Nolan, JP 2019, 'European Resuscitation Council Guidelines for Resuscitation: 2018 Update – Antiarrhythmic drugs for cardiac arrest', Resuscitation, vol. 134, pp. 99-103. https://doi.org/10.1016/j.resuscitation.2018.11.018

TY - JOUR

T1 - European Resuscitation Council Guidelines for Resuscitation

T2 - 2018 Update – Antiarrhythmic drugs for cardiac arrest

AU - Soar, Jasmeet

AU - Perkins, Gavin D.

AU - Maconochie, Ian

AU - Böttiger, Bernd W.

AU - Deakin, Charles D.

AU - Sandroni, Claudio

AU - Olasveengen, Theresa M.

AU - Wyllie, Jonathan

AU - Greif, Robert

AU - Lockey, Andrew

AU - Semeraro, Federico

AU - Van de Voorde, Patrick

AU - Lott, Carsten

AU - Bossaert, Leo

AU - Monsieurs, Koenraad G.

AU - Nolan, Jerry P.

PY - 2019/1

Y1 - 2019/1

N2 - This European Resuscitation Council (ERC) Guidelines for Resuscitation 2018 update is focused on the role of antiarrhythmic drugs during advanced life support for cardiac arrest with shock refractory ventricular fibrillation/pulseless ventricular tachycardia in adults, children and infants. This update follows the publication of the International Liaison Committee on Resuscitation (ILCOR) 2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations (CoSTR). The ILCOR CoSTR suggests that any beneficial effects of amiodarone or lidocaine are similar. This ERC update does not make any major changes to the recommendations for the use of antiarrhythmic drugs during advanced life support for shock refractory cardiac arrest.

AB - This European Resuscitation Council (ERC) Guidelines for Resuscitation 2018 update is focused on the role of antiarrhythmic drugs during advanced life support for cardiac arrest with shock refractory ventricular fibrillation/pulseless ventricular tachycardia in adults, children and infants. This update follows the publication of the International Liaison Committee on Resuscitation (ILCOR) 2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations (CoSTR). The ILCOR CoSTR suggests that any beneficial effects of amiodarone or lidocaine are similar. This ERC update does not make any major changes to the recommendations for the use of antiarrhythmic drugs during advanced life support for shock refractory cardiac arrest.

KW - Advanced life support

KW - Amiodarone

KW - Antiarrhythmic drugs

KW - Cardiopulmonary resuscitation

KW - Guidelines

KW - Heart arrest

KW - Lidocaine

KW - Neonatal life support

KW - Paediatric life support

KW - Pulseless ventricular tachycardia

KW - Ventricular fibrillation

UR - https://www.scopus.com/pages/publications/85061598698

U2 - 10.1016/j.resuscitation.2018.11.018

DO - 10.1016/j.resuscitation.2018.11.018

M3 - Article (Academic Journal)

C2 - 30496838

AN - SCOPUS:85061598698

SN - 0300-9572

VL - 134

SP - 99

EP - 103

JO - Resuscitation

JF - Resuscitation

ER -

European Resuscitation Council Guidelines for Resuscitation: 2018 Update – Antiarrhythmic drugs for cardiac arrest

Abstract

Bibliographical note

Keywords

Access to Document

Handle.net

Other files and links

Fingerprint

Cite this